Cargando…

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease

Toll-like receptors (TLRs) in the liver compartment have repeatedly been attributed to the development of non-alcoholic fatty liver disease (NAFLD). Knowledge on TLR expression in blood cells and their relation to intestinal microbiota and NAFLD development is limited. Here, we determined TLR expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumann, Anja, Nier, Anika, Hernández-Arriaga, Angélica, Brandt, Annette, Lorenzo Pisarello, Maria J., Jin, Cheng J., Pilar, Esther, Camarinha-Silva, Amélia, Schattenberg, Jörn M., Bergheim, Ina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426394/
https://www.ncbi.nlm.nih.gov/pubmed/34497333
http://dx.doi.org/10.1038/s41598-021-97346-9
_version_ 1783750036340867072
author Baumann, Anja
Nier, Anika
Hernández-Arriaga, Angélica
Brandt, Annette
Lorenzo Pisarello, Maria J.
Jin, Cheng J.
Pilar, Esther
Camarinha-Silva, Amélia
Schattenberg, Jörn M.
Bergheim, Ina
author_facet Baumann, Anja
Nier, Anika
Hernández-Arriaga, Angélica
Brandt, Annette
Lorenzo Pisarello, Maria J.
Jin, Cheng J.
Pilar, Esther
Camarinha-Silva, Amélia
Schattenberg, Jörn M.
Bergheim, Ina
author_sort Baumann, Anja
collection PubMed
description Toll-like receptors (TLRs) in the liver compartment have repeatedly been attributed to the development of non-alcoholic fatty liver disease (NAFLD). Knowledge on TLR expression in blood cells and their relation to intestinal microbiota and NAFLD development is limited. Here, we determined TLR expression patterns in peripheral blood mononuclear cells (PBMCs) of NAFLD patients and controls, their relation to intestinal microbiota and the impact of TLRs found altered in NAFLD development. Markers of intestinal permeability in blood and TLR mRNA expression in PBMCs were determined in 37 NAFLD patients and 15 age-matched healthy controls. Fecal microbiota composition was evaluated in 21 NAFLD patients and 9 controls using 16S rRNA gene amplicon sequencing. Furthermore, TLR1(−/−) and C57BL/6 mice (n = 5–6/group) were pair-fed a liquid control or a fat-, fructose- and cholesterol-rich diet. Intestinal microbiota composition and markers of intestinal permeability like zonulin and bacterial endotoxin differed significantly between groups with the latter markers being significantly higher in NAFLD patients. Expression of TLR1-8 and 10 mRNA was detectable in PBMCs; however, only TLR1 expression, being higher in NAFLD patients, were significantly positively correlated with the prevalence of Holdemanella genus while negative correlations were found with Gemmiger and Ruminococcus genera. TLR1(−/−) mice were significantly protected from the development of diet-induced NAFLD when compared to wild-type mice. While intestinal microbiota composition and permeability differed significantly between NAFLD patients and healthy subjects, in PBMCs, only TLR1 expression differed between groups. Still, targeting these alterations might be a beneficial approach in the treatment of NAFLD in some patients.
format Online
Article
Text
id pubmed-8426394
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84263942021-09-09 Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease Baumann, Anja Nier, Anika Hernández-Arriaga, Angélica Brandt, Annette Lorenzo Pisarello, Maria J. Jin, Cheng J. Pilar, Esther Camarinha-Silva, Amélia Schattenberg, Jörn M. Bergheim, Ina Sci Rep Article Toll-like receptors (TLRs) in the liver compartment have repeatedly been attributed to the development of non-alcoholic fatty liver disease (NAFLD). Knowledge on TLR expression in blood cells and their relation to intestinal microbiota and NAFLD development is limited. Here, we determined TLR expression patterns in peripheral blood mononuclear cells (PBMCs) of NAFLD patients and controls, their relation to intestinal microbiota and the impact of TLRs found altered in NAFLD development. Markers of intestinal permeability in blood and TLR mRNA expression in PBMCs were determined in 37 NAFLD patients and 15 age-matched healthy controls. Fecal microbiota composition was evaluated in 21 NAFLD patients and 9 controls using 16S rRNA gene amplicon sequencing. Furthermore, TLR1(−/−) and C57BL/6 mice (n = 5–6/group) were pair-fed a liquid control or a fat-, fructose- and cholesterol-rich diet. Intestinal microbiota composition and markers of intestinal permeability like zonulin and bacterial endotoxin differed significantly between groups with the latter markers being significantly higher in NAFLD patients. Expression of TLR1-8 and 10 mRNA was detectable in PBMCs; however, only TLR1 expression, being higher in NAFLD patients, were significantly positively correlated with the prevalence of Holdemanella genus while negative correlations were found with Gemmiger and Ruminococcus genera. TLR1(−/−) mice were significantly protected from the development of diet-induced NAFLD when compared to wild-type mice. While intestinal microbiota composition and permeability differed significantly between NAFLD patients and healthy subjects, in PBMCs, only TLR1 expression differed between groups. Still, targeting these alterations might be a beneficial approach in the treatment of NAFLD in some patients. Nature Publishing Group UK 2021-09-08 /pmc/articles/PMC8426394/ /pubmed/34497333 http://dx.doi.org/10.1038/s41598-021-97346-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Baumann, Anja
Nier, Anika
Hernández-Arriaga, Angélica
Brandt, Annette
Lorenzo Pisarello, Maria J.
Jin, Cheng J.
Pilar, Esther
Camarinha-Silva, Amélia
Schattenberg, Jörn M.
Bergheim, Ina
Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
title Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
title_full Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
title_fullStr Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
title_full_unstemmed Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
title_short Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
title_sort toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426394/
https://www.ncbi.nlm.nih.gov/pubmed/34497333
http://dx.doi.org/10.1038/s41598-021-97346-9
work_keys_str_mv AT baumannanja tolllikereceptor1asapossibletargetinnonalcoholicfattyliverdisease
AT nieranika tolllikereceptor1asapossibletargetinnonalcoholicfattyliverdisease
AT hernandezarriagaangelica tolllikereceptor1asapossibletargetinnonalcoholicfattyliverdisease
AT brandtannette tolllikereceptor1asapossibletargetinnonalcoholicfattyliverdisease
AT lorenzopisarellomariaj tolllikereceptor1asapossibletargetinnonalcoholicfattyliverdisease
AT jinchengj tolllikereceptor1asapossibletargetinnonalcoholicfattyliverdisease
AT pilaresther tolllikereceptor1asapossibletargetinnonalcoholicfattyliverdisease
AT camarinhasilvaamelia tolllikereceptor1asapossibletargetinnonalcoholicfattyliverdisease
AT schattenbergjornm tolllikereceptor1asapossibletargetinnonalcoholicfattyliverdisease
AT bergheimina tolllikereceptor1asapossibletargetinnonalcoholicfattyliverdisease